[ad_1]
Mark Lennihan/AP
Pfizer is experiencing a shortage of penicillin owing to elevated desire and far more diagnoses of syphilis, the enterprise stated in a letter to its customers this 7 days.
The company said there is an “impending inventory out scenario” for choose Bicillin L-A and Bicillin C-R prefilled syringes, Pfizer’s brand name name of injectable penicillin.
Prefilled Bicillin L-A pediatric syringes are anticipated to begin running small by the conclusion of June, while all Bicillin C-R syringes could start out diminishing in the third quarter of this year.
Stock is predicted to get started recovering in the next and third quarters of 2024, Pfizer reported.
Penicillin is an antibiotic used to treat numerous sorts of bacterial infections, which include sexually transmitted diseases, this kind of as syphilis and pneumonia.
Syphilis rates had been at a historic reduced from 2000 to 2001, but have greater just about every calendar year given that, with an increase of 28.6% from 2020 to 2021, which was likely exacerbated by an interruption in remedy and prevention thanks to the COVID-19 pandemic, the Facilities for Illness Management and Prevention said.
The scarcity of penicillin comes amid a extensive-phrase shortage of prescription drugs the U.S. has been enduring for the last decade, normally as a result of disruptions in the provide chain, like the just one brought on by the pandemic, Marta Wosińska, a checking out fellow at The Brookings Establishment, instructed NPR previously this year.
Other prescriptions, these types of as Adderall and kid’s flu medicine have also been in quick provide.
[ad_2]
Source backlink